SeaStar Medical Holding Corporation (ICU) Stock Forecast
ICU analyst forecast
as of October 17, 2026- Analyst consensus
- Buy 4.00 / 5 from 1 analysts
- Price target
- $10.00 average of analyst targets
- Upside to target
- +244.8% from the latest close
- Next earnings
- November 12, 2026 EPS estimate $-0.95
- 52-week range
- $2.21 – $6.31
ICU analyst ratings
1 analystsNumber of analysts at each rating.
ICU price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ICU earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.95 | −$0.95 | −$0.95 | −$1.30 | +26.9% | 1 |
| Current fiscal year (2026) | −$3.66 | −$3.66 | −$3.66 | −$5.86 | +37.5% | 1 |
| Next fiscal year (2027) | −$2.33 | −$2.58 | −$2.09 | −$3.66 | +36.2% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ICU revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $500,000 | $500,000 | $500,000 | +173.2% | 1 |
| Current fiscal year (2026) | $2.0M | $2.0M | $2.0M | +62.1% | 1 |
| Next fiscal year (2027) | $2.9M | $2.9M | $3.0M | +46.6% | 2 |
ICU EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ICU revenue: reported and forecast
ICU EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.90 | −$0.90 | −$0.90 | −$0.90 | −$0.95 | +6.1% | 0 up · 2 down |
| Current fiscal year (2026) | −$3.64 | −$3.64 | −$3.64 | −$3.64 | −$3.66 | +0.5% | 0 up · 2 down |
| Next fiscal year (2027) | −$2.33 | −$2.33 | −$2.33 | −$2.33 | −$2.33 | 0.0% | 0 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ICU earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ICU beat in 7 of 12.
What analysts expect from ICU
1 analysts cover SeaStar Medical; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $10.00, 244.8% above the latest close of $2.90. Analysts expect earnings of −$3.66 per share for 2026, +37.5% from a year earlier. For 2027 the average estimate is −$2.33 per share on revenue of $2.9 million. SeaStar Medical beat the EPS estimate in 7 of the last 12 quarters.
Related: ICU income statement, ICU key metrics, ICU chart. See the ICU stock overview for the latest quote and news.
ICU forecast FAQ
What is SeaStar Medical's price target?
The average analyst price target for SeaStar Medical is $10.00, 244.8% above the latest close of $2.90.
Is SeaStar Medical a buy, hold or sell?
Of 1 analysts covering SeaStar Medical, 0 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is SeaStar Medical's EPS forecast?
Analysts forecast −$3.66 per share for 2026 (range −$3.66 to −$3.66); for 2027 the estimate is −$2.33.
What is SeaStar Medical's revenue forecast?
The average revenue estimate for 2026 is $2.0 million, growth of 62.1%; for 2027 it is $2.9 million.
When does SeaStar Medical report earnings?
SeaStar Medical is expected to report results for the quarter ending September 30, 2026 on November 12, 2026; the EPS estimate is $-0.95.
Does SeaStar Medical usually beat earnings estimates?
SeaStar Medical reported EPS at or above the analyst estimate in 7 of the last 12 quarters.